TP53 and breast cancer: Second, our study incorporated the explicit age-specific effects of PVs in PALB2, CHEK2, ATM, and TP53 in addition to BRCA1 and BRCA2 while modeling the residual familial variance of breast cancer as a function of age with a polygenic component.